Abstract
Background: Phosphate level is a potent independent risk factor for cardiovascular disease and mortality in patients with chronic kidney disease. The association between hypophosphatemia and kidney function in kidney transplant patients is uncertain. Methods: In total, 90 kidney transplant recipients were divided into two groups: one group of patients with hypophosphatemia and the other group without hypophosphatemia. The recipients with hypophosphatemia were identified as having less than or equal to the lowest quartile of serum phosphate levels at 1-, 3-, and 12-month post-transplant. The cumulative kidney survival rates were calculated for each group using the Kaplan–Meier method, and the adjusted hazard ratio (HR) was calculated using the Cox regression model. Results: The mean age of patients was 47 years and the median follow-up period was 58 months. During the follow-up period, the following results were demonstrated in 90 transplant patients: graft loss (n = 6), mortality (n = 3). According to the Kaplan–Meier analysis results, the patients with hypophosphatemia demonstrated a significantly lower risk of 30% decline in eGFR compared to those without hypophosphatemia at 1- and 3-month post-transplant, but not at 12-month post-transplant. After adjusting for confounding factors, hypophosphatemia at 1- and 3-month post-transplant was an independent predictor of good kidney survival (HR 0.31, 95% CI 0.10–0.82 and HR 0.31, 95% CI 0.07–0.92, respectively). Conclusions: Our findings suggest that hypophosphatemia during the first 3 months after kidney transplantation was associated with better kidney survival.
| Original language | English |
|---|---|
| Pages (from-to) | 1161-1168 |
| Number of pages | 8 |
| Journal | Clinical and Experimental Nephrology |
| Volume | 23 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sep 1 2019 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Physiology
- Nephrology
- Physiology (medical)
Cite this
Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function. / Nakai, Kentaro; Mitsuiki, Koji; Kuroki, Yusuke; Nishiki, Takehiro; Motoyama, Kentaro; Nakano, Toshiaki; Kitazono, Takanari.
In: Clinical and Experimental Nephrology, Vol. 23, No. 9, 01.09.2019, p. 1161-1168.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function
AU - Nakai, Kentaro
AU - Mitsuiki, Koji
AU - Kuroki, Yusuke
AU - Nishiki, Takehiro
AU - Motoyama, Kentaro
AU - Nakano, Toshiaki
AU - Kitazono, Takanari
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Background: Phosphate level is a potent independent risk factor for cardiovascular disease and mortality in patients with chronic kidney disease. The association between hypophosphatemia and kidney function in kidney transplant patients is uncertain. Methods: In total, 90 kidney transplant recipients were divided into two groups: one group of patients with hypophosphatemia and the other group without hypophosphatemia. The recipients with hypophosphatemia were identified as having less than or equal to the lowest quartile of serum phosphate levels at 1-, 3-, and 12-month post-transplant. The cumulative kidney survival rates were calculated for each group using the Kaplan–Meier method, and the adjusted hazard ratio (HR) was calculated using the Cox regression model. Results: The mean age of patients was 47 years and the median follow-up period was 58 months. During the follow-up period, the following results were demonstrated in 90 transplant patients: graft loss (n = 6), mortality (n = 3). According to the Kaplan–Meier analysis results, the patients with hypophosphatemia demonstrated a significantly lower risk of 30% decline in eGFR compared to those without hypophosphatemia at 1- and 3-month post-transplant, but not at 12-month post-transplant. After adjusting for confounding factors, hypophosphatemia at 1- and 3-month post-transplant was an independent predictor of good kidney survival (HR 0.31, 95% CI 0.10–0.82 and HR 0.31, 95% CI 0.07–0.92, respectively). Conclusions: Our findings suggest that hypophosphatemia during the first 3 months after kidney transplantation was associated with better kidney survival.
AB - Background: Phosphate level is a potent independent risk factor for cardiovascular disease and mortality in patients with chronic kidney disease. The association between hypophosphatemia and kidney function in kidney transplant patients is uncertain. Methods: In total, 90 kidney transplant recipients were divided into two groups: one group of patients with hypophosphatemia and the other group without hypophosphatemia. The recipients with hypophosphatemia were identified as having less than or equal to the lowest quartile of serum phosphate levels at 1-, 3-, and 12-month post-transplant. The cumulative kidney survival rates were calculated for each group using the Kaplan–Meier method, and the adjusted hazard ratio (HR) was calculated using the Cox regression model. Results: The mean age of patients was 47 years and the median follow-up period was 58 months. During the follow-up period, the following results were demonstrated in 90 transplant patients: graft loss (n = 6), mortality (n = 3). According to the Kaplan–Meier analysis results, the patients with hypophosphatemia demonstrated a significantly lower risk of 30% decline in eGFR compared to those without hypophosphatemia at 1- and 3-month post-transplant, but not at 12-month post-transplant. After adjusting for confounding factors, hypophosphatemia at 1- and 3-month post-transplant was an independent predictor of good kidney survival (HR 0.31, 95% CI 0.10–0.82 and HR 0.31, 95% CI 0.07–0.92, respectively). Conclusions: Our findings suggest that hypophosphatemia during the first 3 months after kidney transplantation was associated with better kidney survival.
UR - http://www.scopus.com/inward/record.url?scp=85067673907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067673907&partnerID=8YFLogxK
U2 - 10.1007/s10157-019-01756-z
DO - 10.1007/s10157-019-01756-z
M3 - Article
VL - 23
SP - 1161
EP - 1168
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
SN - 1342-1751
IS - 9
ER -